Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $425.1200 (3.43%) ($409.9900 - $425.8800) on Fri. Jul. 29, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.15% (three month average) | RSI | 76 | Latest Price | $425.1200(3.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.7% a day on average for past five trading days. | Weekly Trend | REGN advances 5.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(62%) XLV(50%) XBI(46%) IVW(40%) IWF(40%) | Factors Impacting REGN price | REGN will decline at least -1.075% in a week (0% probabilities). VIXM(-9%) UUP(-7%) TLT(-7%) IPO(-6%) TIP(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.075% (StdDev 2.15%) | Hourly BBV | 0 () | Intraday Trend | 3.4% | | | |
|
5 Day Moving Average | $408.88(3.97%) | 10 Day Moving Average | $397.76(6.88%) | 20 Day Moving Average | $383.85(10.75%) | To recent high | 0% | To recent low | 28.4% | Market Cap | $45.075b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |